Antibiotice Iasi 1Q Profit Down 26% To RON5.3M, Turnover Up 1% To RON55.4M

05.15.2017 By Ecaterina Craciun

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Monday said it registered a profit of RON5.3 million in January-March 2017, down 26% on the year.



To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 25 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
Antibiotice Iasi
, results

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.